Literature DB >> 18042129

Benefits of hormone replacement therapy in postmenopausal women.

Richard Canderelli1, Lisa A Leccesse, Nancy L Miller, Janice Unruh Davidson.   

Abstract

PURPOSE: To provide an overview of current research regarding hormone replacement therapy (HRT) and to assist healthcare providers to better educate patients about potential benefits of this therapy. DATA SOURCES: A systematic review of healthcare literature was conducted with 602 articles selected from CINAHL, Medscape, Pubmed, and Medline databases. Keywords directing the search included hormone replacement therapy, benefits of hormone replacement therapy and trends, hormone replacement therapy and osteoporosis, hormone replacement, and menopause symptoms.
CONCLUSIONS: According to the literature, HRT can assist women with postmenopausal symptoms. In addition, research shows that HRT can help some postmenopausal women with selected comorbid conditions such as osteoporosis, type II diabetes, certain cardiovascular pathologies, and colorectal cancer. The decision as to who should use any form of HRT needs to be based on the individual woman's needs, quality of life, and potential risks versus benefits. IMPLICATIONS FOR PRACTICE: HRT has been a benefit to many women in the treatment of postmenopausal symptoms. Recent studies have shown that HRT, whether it is combined estrogen and progestin therapy, or estrogen-only therapy, can help postmenopausal women with osteoporosis and some selected comorbid conditions. Recent research indicates that some women are dying from comorbid conditions rather than breast cancer. Although the research regarding HRT in some areas may be limited, further research adds to existing knowledge and offers new ideas and possibilities in the treatment of postmenopausal symptoms and selected comorbid conditions. Certainly HRT can improve quality of life and possibly longevity for selected women. Ongoing research is needed to further validate such benefits, as well as to further explore the risks and benefits of long-term HRT. Increased knowledge about HRT will help healthcare providers better educate patients about the potential benefits of HRT, while providing documentation about who should take selected types of HRT or whether alternative treatment is preferred.

Entities:  

Mesh:

Year:  2007        PMID: 18042129     DOI: 10.1111/j.1745-7599.2007.00269.x

Source DB:  PubMed          Journal:  J Am Acad Nurse Pract        ISSN: 1041-2972


  17 in total

1.  Could recent decreases in breast cancer incidence really be due to lower HRT use? Trends in attributable risk for modifiable breast cancer risk factors in Canadian women.

Authors:  C Ineke Neutel; Howard Morrison
Journal:  Can J Public Health       Date:  2010 Sep-Oct

2.  Using 4-vinylcyclohexene diepoxide as a model of menopause for cardiovascular disease.

Authors:  John P Konhilas; Jessica N Sanchez; Jessica A Regan; Eleni Constantopoulos; Marissa Lopez-Pier; Danielle K Cannon; Rinku Skaria; Laurel A McKee; Hao Chen; Yulia Lipovka; Dennis Pollow; Heddwen L Brooks
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-08       Impact factor: 4.733

3.  Comparative Assessment of the Effects of Hatha Yoga and Physical Exercise on Biochemical Functions in Perimenopausal Women.

Authors:  Abhishek Chaturvedi; Gayathry Nayak; Akshatha Ganesh Nayak; Anjali Rao
Journal:  J Clin Diagn Res       Date:  2016-08-01

4.  Suboptimal management of severe menopausal symptoms by Nigerian Gynaecologists: a call for mandatory continuing medical education for physicians.

Authors:  Peter O Nkwo
Journal:  BMC Womens Health       Date:  2009-10-23       Impact factor: 2.809

5.  Loss of ovarian function in the VCD mouse-model of menopause leads to insulin resistance and a rapid progression into the metabolic syndrome.

Authors:  Melissa J Romero-Aleshire; Maggie K Diamond-Stanic; Alyssa H Hasty; Patricia B Hoyer; Heddwen L Brooks
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-13       Impact factor: 3.619

6.  17beta-Estradiol-induced enhancement of estrogen receptor biosynthesis via MAPK pathway in mouse skeletal muscle myoblasts.

Authors:  J Hatae; N Takami; Hai Lin; Akira Honda; R Inoue
Journal:  J Physiol Sci       Date:  2009-02-25       Impact factor: 2.781

7.  Naringenin: a partial agonist on estrogen receptor in T47D-KBluc breast cancer cells.

Authors:  Sunzoo Kim; Tae In Park
Journal:  Int J Clin Exp Med       Date:  2013-10-25

Review 8.  The VCD Mouse Model of Menopause and Perimenopause for the Study of Sex Differences in Cardiovascular Disease and the Metabolic Syndrome.

Authors:  H L Brooks; D P Pollow; P B Hoyer
Journal:  Physiology (Bethesda)       Date:  2016-07

Review 9.  Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis.

Authors:  MinFang Tao; YinCheng Teng; HongFang Shao; Ping Wu; Edward J Mills
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

10.  Phytoestrogen α-zearalanol ameliorates memory impairment and neuronal DNA oxidation in ovariectomized mice.

Authors:  Yilong Dong; Yanmei Wang; Yanyong Liu; Nan Yang; Pingping Zuo
Journal:  Clinics (Sao Paulo)       Date:  2013-09       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.